About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology
Free SOHO Membership:
www.sohoonline.org
SOHO 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Videos
SOHO 2022
Myeloma
Lymphoma
Leukemia
MDS and MPN
Benign Hematology
SOHO 2021
Myeloma
Cellular Therapy
Solid Tumors
Leukemia
MDS
Benign Hematology
MPN
Lymphoma
SOHO 2020
Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
SOHO Highlights: State of the Art and Next Questions
SOHO 2019
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
SOHO 2018
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Session VI: Multiple Myeloma
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Plenary Sessions
Breakfast with the Expert
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
SOHO 2021 Debate on the Optimal Time for Blinatumomab in ALL: Is It Time for MRD?
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Rachel Rau
By
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
FEATURING
Rachel Rau
50 views
September 18, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Leukemia
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in ALL
Feat.
B. Shah
09:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in AML
Feat.
H. Kantarjian
10:37
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in CLL
Feat.
S. O'Brien
11:49
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Next Questions in CML
Feat.
J. Cortés
16:18
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Managing TKI Resistance in CML: New Options
Feat.
D. Rea
16:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update: State-of-the-Art in CML
Feat.
A. Hochhaus
16:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on CML and Pregnancy
Feat.
E. Abruzzese
11:12
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 OPTIC Primary Analysis on CP-CML: A Dose-Optimization Stud…
Feat.
J. Cortés
14:51
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Treatment-Free Remission in CML
Feat.
E. Atallah
21:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Case Study: Managing Cytopenias on TKI Therapy in CML
Feat.
J. Apperley
18:11
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on the Use of MRD in CLL: American Perspective
Feat.
M. Davids
24:58
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on the Use of MRD in CLL: European Perspective
Feat.
O. Al-Sawaf
17:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on CLL: Molecular and Microenvironmental Basis of I…
Feat.
S. Deaglio
15:56
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Management of Infections in Patients With CLL
Feat.
C. Niemann
11:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Debate: Do Old Prognostic Markers Still Have a Role in CLL…
Feat.
I. Ahn
10:25
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Debate on Old Prognostic Markers in CLL Management: Do The…
Feat.
S. Coutre
18:18
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Approaches to Therapy of Richter's Syndrome in CLL
Feat.
D. Rossi
16:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: New Targetable Pathways in CLL
Feat.
A. Danilov
08:20
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 BRUIN Trial Update on Previously Treated CLL/SLL: Pirtobru…
Feat.
C. Coombs
20:46
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on the Management of Advanced CML: Blast Crisis
Feat.
M. Deininger
11:04
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: How Can We Improve on AML MRD Assessment by Flow Cytometry
Feat.
S. Freeman
12:54
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Menin Inhibitors in AML: What Are the Prospects?
Feat.
E. Wang
09:10
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Novel Strategies to Treat Elderly With AML
Feat.
T. Kadia
13:23
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Conventional Chemotherapy-Free Regimens in ALL
Feat.
M. Wieduwilt
09:58
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on the Approach to Ph+ ALL: From Worst to Best?
Feat.
P. Kebriaei
13:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Chemoresistance and Drug Profiling in ALL
Feat.
B. Bornhauser
16:00
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Data on the Resistance to BCL-2i in CLL
Feat.
C. Tam
11:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Data on the Resistance to BTKi in CLL
Feat.
J. Woyach
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on Cellular Therapy for CLL
Feat.
T. Kipps
13:01
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on the Genomically Guided Frontline Therapy in CML
Feat.
T. Hughes
14:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Molecular Testing of CML Patients: Between Old a…
Feat.
S. Soverini
13:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on the Approach to the Elderly Patients With AL…
Feat.
S. Chiaretti
16:02
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Novel Transplant and Post-transplant Options in …
Feat.
A. Logan
10:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on the Use of BCL2i in ALL: Targeting Apoptosis
Feat.
W. Stock
16:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Familial Predisposition to AML: How Far Are We i…
Feat.
L. Godley
16:28
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021: Beyond BCL2 Inhibition & Prospects for MCL1 Inhibitor…
Feat.
M. Konopleva
11:43
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights on Single Cell Profiling in AML
Feat.
K. Takahashi
12:32
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Case Study: 1L Treatment in an Older Patient With TN-CLL W…
Feat.
N. Lamanna
05:15
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Case Study: Relapse After 1L BTKi Therapy in RR-CLL Patien…
Feat.
N. Lamanna
07:42
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Case Review: CLL Refractory to BTKi and to Venetoclax
Feat.
J. Burke
06:17
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Case Review: Richter's Transformation of CLL to DLBCL
Feat.
J. Burke
06:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…
Feat.
D. Stephens
05:31
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…
Feat.
D. Stephens
12:12
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Response and Progression in CML
Feat.
J. Radich
14:59
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on the Importance of BCR-ABL Transcript Type in CML
Feat.
N. Cross
13:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Highlights on New Drugs and New Challenges in CML
Feat.
J. Cortés
14:55
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Updates on Hyper-CVAD in ALL: Lessons Learned and New Appr…
Feat.
E. Jabbour
17:27
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on MRD in ALL: Techniques and Therapeutic Utility O…
Feat.
L. Muffly
13:24
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Data on Novel CAR-T Constructs for ALL
Feat.
P. Lu
15:27
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Updates on Asparaginase in Adults With ALL: Understanding …
Feat.
I. Aldoss
15:45
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Highlights: Novel Approaches to T-Cell ALL
Feat.
D. Teachey
14:47
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Debate on the Optimal Time for Blinatumomab in ALL: Is It …
Feat.
R. Rau
12:59
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Debate on the Optimal Time for CAR-T in Pediatric B-ALL: I…
Feat.
R. Gardner
11:36
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on Childhood ALL: The Impact of Genetic Ancestry on…
Feat.
S. Lee
15:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on IDH-Mutated AML: Beyond Enasidenib and Ivosideni…
Feat.
C. DiNardo
15:44
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on FLT3-Mutated AML: Moving Towards Cure
Feat.
A. Perl
12:33
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on Antibody-Based Therapy in AML: Immunotoxins and …
Feat.
A. Fathi
15:40
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 New Horizons in TP53-Mutated AML
Feat.
N. Daver
14:05
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Debate on the Maintenance Therapy in AML: Is It Necessary?
Feat.
F. Ravandi
16:14
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Debate: Is Maintenance Therapy in AML Necessary?
Feat.
J. Lancet
15:41
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Highlights on MRD in AML
Feat.
J. Cloos
10:57
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
2021 SOHO Update on Newly Diagnosed AML: Venetoclax Combined With FL…
Feat.
C. Lachowiez
08:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Update on Algorithmic Diagnostic Approach and Spectrum of …
Feat.
A. Ferrer
17:39
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
SOHO 2021 Updates on Managing CLL Patients Relapsed or Refractory to…
Feat.
J. Brown
